Sign in

CIK 0001398733

  • Non-accelerated filer
  • Smaller reporting company

Aquestive Therapeutics, Inc.

Sign in to watch
Ticker
AQST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208623253
Phone
+1 908-941-1900
Business address
184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
Former names
MonoSol Rx, Inc.
  1. 4 Planned sale Chief Innovation/Tech Officer sold 50,000 shares at $6.00 ($300,000)
  2. 4 Shares withheld for taxes President and CEO gave up 37,938 shares (to pay taxes)
  3. 4 Shares withheld for taxes Boyd Peter E. gave up 8,370 shares (to pay taxes)
  4. 4 Shares withheld for taxes SVP, General Counsel gave up 10,530 shares (to pay taxes)
  5. 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 11,705 shares (to pay taxes)
  6. 4 Shares withheld for taxes SVP, Research & Development gave up 12,956 shares (to pay taxes)
  7. 4 Shares withheld for taxes SVP, Operations gave up 9,432 shares (to pay taxes)
  8. 4 Planned sale Chief Innovation/Tech Officer sold 25,000 shares at $5.19 ($129,685)
  9. 4 Grant or award SVP, General Counsel acquired 135,000 shares (grant or award)
  10. 4 Grant or award SVP, Chief Financial Officer acquired 120,000 shares (grant or award)
  11. 4 Grant or award Chief Innovation/Tech Officer acquired 82,500 shares (grant or award)
  12. 4 Grant or award Chief Medical Officer acquired 112,500 shares (grant or award)
  13. 4 Grant or award President and CEO acquired 242,600 shares (grant or award)
  14. 4 Grant or award SVP, Operations acquired 101,250 shares (grant or award)
  15. 4 Grant or award Boyd Peter E. acquired 86,250 shares (grant or award)
  16. 4 Shares withheld for taxes SVP, Research & Development gave up 1,981 shares (to pay taxes)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 6 of 17 · 326 filings